Published in Case Rep Oncol on September 11, 2010
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst (2006) 6.58
Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie. N Engl J Med (1998) 4.93
The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol (2006) 3.88
The natural history of incidentally detected small renal masses. Cancer (2004) 2.57
Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol (2008) 2.45
Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol (2002) 2.43
Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer (2008) 1.64
Enhancing renal masses with zero net growth during active surveillance. J Urol (2007) 1.59
Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol (2005) 1.55
Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial. J Clin Oncol (2003) 1.49
A description of radical nephrectomy practice and outcomes in England: 1995-2002. BJU Int (2005) 1.46
Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol (2007) 1.36
Management of renal masses in patients medically unsuitable for nephrectomy--natural history, complications, and outcome. Urology (2004) 1.35
Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer (2007) 1.20
The natural history of small renal masses. J Urol (2000) 1.19
Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol (2004) 1.10
Observations on the growth rate of renal cell carcinoma. Int J Urol (1995) 0.91